BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18998463)

  • 1. [Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].
    Luo Y; He DL; Jiang YG; Li MC; Ning L; Shen SL
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):800-4. PubMed ID: 18998463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Over-expression of Hypoxia-inducible factor 1alpha increases invasive potency of LNCaP cells in vitro].
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2285-8. PubMed ID: 17064578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X; Zhau HE; Chung LW
    BJU Int; 2006 Dec; 98(6):1315-9. PubMed ID: 16956360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
    Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Over-expression of hypoxia-inducible factor-1 alpha increases angiogenesis of LNCaP cells].
    Han YL; He DL; Luo Y; Cheng HP; Zhu GF
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):988-91. PubMed ID: 18077909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Over-expression of hypoxia-inducible factor-1alpha induces epithelial-mesenchymal transition in LNCaP cells in vitro and in vivo].
    Han YL; Luo Y; He DL; Cheng YY; Xu YG
    Zhonghua Nan Ke Xue; 2012 Jan; 18(1):23-8. PubMed ID: 22295844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].
    Luo Y; He DL; Ning L
    Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].
    Zhu GF; Cheng HP; Wu KJ; Zhang LL; Zhu GD; Zhang D; He DL
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):238-41. PubMed ID: 18488338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epithelial-mesenchymal transition of prostate cancer: cancer stem cells or bulk cancer cells].
    Luo Y; Cui XH; Jiang YG; He DL; Zhao JH; Zhao L; Chen YT; Li MC; Lin YH
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):256-60. PubMed ID: 23578503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].
    Han YL; He DL; Luo Y; Cheng HP; Zhu GF
    Zhonghua Nan Ke Xue; 2008 May; 14(5):439-44. PubMed ID: 18572865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
    Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
    Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].
    Luo Y; He DL; Ning L; Zhu GD; Shen SL
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):230-3. PubMed ID: 16597039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of E-cadherin and beta-catenin in LNCaP and ARCaP cell lines and their significance].
    Jiang YG; Zhao JH; Luo Y; He DL; Li N; Cui XH; Peng T
    Zhonghua Nan Ke Xue; 2009 Oct; 15(10):867-71. PubMed ID: 20112731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of prostate cancer cell lines and their epithelial-mesenchymal transition in subcutaneous tumors].
    Zhao L; Jiang YG; Ma J; Luo Y; Zhao JH
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):314-7. PubMed ID: 21548207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of transcription factors repressing epithelial phenotype in two different prostate cancer EMT models and its significance].
    Wu KJ; Zeng J; Zhu GD; Zhang D; Xue Y; Chen YL; Wang XY; He DL
    Zhonghua Nan Ke Xue; 2010 Feb; 16(2):137-41. PubMed ID: 20369697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inducible expression of hypoxia-inducible factor 1alpha on the proliferation and invasion property of HepG2 cells under normoxia in vitro].
    Jin WD; Chen XP; Yang SL; Xu ZQ; Zhang WG
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1634-6. PubMed ID: 18453222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
    Monsef N; Helczynski L; Lundwall A; PĂ„hlman S;
    Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.